These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 27207466)

  • 1. Circadian disturbance and idiopathic central serous chorioretinopathy.
    Setrouk E; Hubault B; Vankemmel F; Zambrowski O; Nazeyrollas P; Delemer B; Durlach V; Ducasse A; Arndt C
    Graefes Arch Clin Exp Ophthalmol; 2016 Nov; 254(11):2175-2181. PubMed ID: 27207466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low luminance visual acuity in patients with central serous chorioretinopathy.
    Fujita K; Shinoda K; Matsumoto CS; Imamura Y; Mizutani Y; Tanaka E; Mizota A; Oda K; Yuzawa M
    Clin Exp Optom; 2013 Jan; 96(1):100-5. PubMed ID: 22963010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shift Work: A Risk Factor for Central Serous Chorioretinopathy.
    Bousquet E; Dhundass M; Lehmann M; Rothschild PR; Bayon V; Leger D; Bergin C; Dirani A; Beydoun T; Behar-Cohen F
    Am J Ophthalmol; 2016 May; 165():23-8. PubMed ID: 26915576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photodynamic therapy as treatment of chronic idiopathic central serous chorioretinopathy.
    Tarantola RM; Law JC; Recchia FM; Sternberg P; Agarwal A
    Lasers Surg Med; 2008 Dec; 40(10):671-5. PubMed ID: 19065564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of photodynamic therapy in steroid-associated chronic central serous chorioretinopathy: a case-control study.
    Breukink MB; Mohabati D; van Dijk EH; den Hollander AI; de Jong EK; Dijkman G; Keunen JE; Hoyng CB; Boon CJ
    Acta Ophthalmol; 2016 Sep; 94(6):565-72. PubMed ID: 27149889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Half-fluence photodynamic therapy in chronic central serous chorioretinopathy.
    Smretschnig E; Ansari-Shahrezaei S; Hagen S; Glittenberg C; Krebs I; Binder S
    Retina; 2013 Feb; 33(2):316-23. PubMed ID: 23314238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photodynamic therapy for chronic central serous chorioretinopathy: a 4-year follow-up study.
    Silva RM; Ruiz-Moreno JM; Gomez-Ulla F; Montero JA; Gregório T; Cachulo ML; Pires IA; Cunha-Vaz JG; Murta JN
    Retina; 2013 Feb; 33(2):309-15. PubMed ID: 23095766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Annular Lesions and Catenary Forms in Chronic Central Serous Chorioretinopathy.
    Dansingani KK; Balaratnasingam C; Mrejen S; Inoue M; Freund KB; Klancnik JM; Yannuzzi LA
    Am J Ophthalmol; 2016 Jun; 166():60-67. PubMed ID: 27021439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fundus autofluorescence and visual acuity in central serous chorioretinopathy.
    Imamura Y; Fujiwara T; Spaide RF
    Ophthalmology; 2011 Apr; 118(4):700-5. PubMed ID: 21055816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased risk of erectile dysfunction among males with central serous chorioretinopathy -- a retrospective cohort study.
    Tsai DC; Huang CC; Chen SJ; Chou P; Chung CM; Chan WL; Huang PH; Lin SJ; Chen JW; Leu HB
    Acta Ophthalmol; 2013 Nov; 91(7):666-71. PubMed ID: 22998678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic findings associated with central serous chorioretinopathy.
    Tittl MK; Spaide RF; Wong D; Pilotto E; Yannuzzi LA; Fisher YL; Freund B; Guyer DR; Slakter JS; Sorenson JA
    Am J Ophthalmol; 1999 Jul; 128(1):63-8. PubMed ID: 10482095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of metamorphopsia in chronic central serous chorioretinopathy after half-dose verteporfin photodynamic therapy.
    Fujita K; Imamura Y; Shinoda K; Matsumoto CS; Mizutani Y; Mizota A; Yuzawa M
    Retina; 2014 May; 34(5):964-70. PubMed ID: 24406387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement in visual acuity and contrast sensitivity in patients with central serous chorioretinopathy after macular subthreshold laser therapy.
    Behnia M; Khabazkhoob M; Aliakbari S; Abadi AE; Hashemi H; Pourvahidi P
    Retina; 2013 Feb; 33(2):324-8. PubMed ID: 23314231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum cortisol and testosterone levels in idiopathic central serous chorioretinopathy.
    Zakir SM; Shukla M; Simi ZU; Ahmad J; Sajid M
    Indian J Ophthalmol; 2009; 57(6):419-22. PubMed ID: 19861741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors for Central Serous Chorioretinopathy: Multivariate Approach in a Case-Control Study.
    Chatziralli I; Kabanarou SA; Parikakis E; Chatzirallis A; Xirou T; Mitropoulos P
    Curr Eye Res; 2017 Jul; 42(7):1069-1073. PubMed ID: 28306346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Multicenter Study on the Long-term Outcomes of Half-dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy.
    Lai FH; Ng DS; Bakthavatsalam M; Chan VC; Young AL; Luk FO; Tsang CW; Brelén ME
    Am J Ophthalmol; 2016 Oct; 170():91-99. PubMed ID: 27519561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of central serous chorioretinopathy in adults prescribed oral corticosteroids: a population-based study in Taiwan.
    Tsai DC; Chen SJ; Huang CC; Chou P; Chung CM; Chan WL; Huang PH; Lin SJ; Chen JW; Chen TJ; Leu HB
    Retina; 2014 Sep; 34(9):1867-74. PubMed ID: 24743638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-year choroidal thickness results after photodynamic therapy for central serous chorioretinopathy.
    Maruko I; Iida T; Sugano Y; Furuta M; Sekiryu T
    Retina; 2011 Oct; 31(9):1921-7. PubMed ID: 21878850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical factors related to visual outcome in central serous chorioretinopathy.
    Aggio FB; Roisman L; Melo GB; Lavinsky D; Cardillo JA; Farah ME
    Retina; 2010; 30(7):1128-34. PubMed ID: 20616688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central serous chorioretinopathy: a review of epidemiology and pathophysiology.
    Liew G; Quin G; Gillies M; Fraser-Bell S
    Clin Exp Ophthalmol; 2013 Mar; 41(2):201-14. PubMed ID: 22788735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.